Federation des caisses Desjardins du Quebec’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.7K | Hold |
1,416
| – | – | ﹤0.01% | 1570 |
|
|
2025
Q1 | $45K | Buy |
1,416
+1,062
| +300% | +$33.8K | ﹤0.01% | 1502 |
|
|
2024
Q4 | $13.7K | Hold |
354
| – | – | ﹤0.01% | 1771 |
|
|
2024
Q3 | $15.9K | Hold |
354
| – | – | ﹤0.01% | 1732 |
|
|
2024
Q2 | $14.8K | Hold |
354
| – | – | ﹤0.01% | 1698 |
|
|
2024
Q1 | $16.1K | Hold |
354
| – | – | ﹤0.01% | 1694 |
|
|
2023
Q4 | $16.4K | Hold |
354
| – | – | ﹤0.01% | 1634 |
|
|
2023
Q3 | $14.4K | Hold |
354
| – | – | ﹤0.01% | 1660 |
|
|
2023
Q2 | $17.2K | Sell |
354
-25
| -7% | -$1.21K | ﹤0.01% | 1619 |
|
|
2023
Q1 | $18.7K | Hold |
379
| – | – | ﹤0.01% | 1588 |
|
|
2022
Q4 | $19.2K | Hold |
379
| – | – | ﹤0.01% | 1691 |
|
|
2022
Q3 | $19K | Hold |
379
| – | – | ﹤0.01% | 1749 |
|
|
2022
Q2 | $18.5K | Buy |
379
+87
| +30% | +$4.25K | ﹤0.01% | 1783 |
|
|
2022
Q1 | $17.5K | Buy |
292
+4
| +1% | +$240 | ﹤0.01% | 1866 |
|
|
2021
Q4 | $22.8K | Buy |
288
+25
| +10% | +$1.98K | ﹤0.01% | 1793 |
|
|
2021
Q3 | $23.2K | Hold |
263
| – | – | ﹤0.01% | 1807 |
|
|
2021
Q2 | $26.1K | Buy |
263
+182
| +225% | +$18.1K | ﹤0.01% | 1786 |
|
|
2021
Q1 | $7.31K | Buy |
+81
| New | +$7.31K | ﹤0.01% | 2079 |
|